Much of the published evidence supporting this hypothesis comes from studies investigating changes that occur due to increased Aβ production as a result of mutations in either APP or in presenilin 1 (PSEN-1) or PSEN-2, components of the γ-secretase complex, that occur in familial AD (fAD). Here, APP is linked to familial Alzheimer disease.